Literature DB >> 11232703

Functional hepatic volume measured by technetium-99m-galactosyl-human serum albumin liver scintigraphy: comparison between hepatocyte volume and liver volume by computed tomography.

A H Kwon1, Y Matsui, S K Ha-Kawa, Y Kamiyama.   

Abstract

OBJECTIVES: We investigated the usefulness of measuring the functional hepatic volume by single-photon emission CT with 99m-technetium galactosyl-human serum albumin scintigraphy (GSA-LV). We then compared this value to the total hepatocyte volume and the hepatic volume determined from CT (CT-LV) in the patients with hepatobiliary tumors.
METHODS: Forty-seven patients were divided into two groups, the SM group (subsegmentectomy and monosegmentectomy) and the DT group (disegmentectomy and trisegmentectomy). These groups were further divided into subgroups with or without chronic hepatitis or cirrhosis. The GSA-LV, CT-LV, and the total hepatocyte volume were then calculated. The GSA-LV and CT-LV measurements were performed preoperatively, at 2 and 4 wk, and at 3 and 6 months after surgery.
RESULTS: The preoperative GSA-LV values were significantly correlated with the hepatocyte volume and the 15-min retention rate of indocyanine green (ICGR15). Similarly, the hepatocyte volume correlated well with the CT-LV and ICGR15. However, the CT-LV was correlated only with the ICGR15. Recovery of the GSA-LV in the DT group was delayed, and about 90% of the volumetric and functional regeneration was observed within 6 months after the hepatectomy. In contrast, the CT-LV of DT group patients with normal liver remnants returned to approximately 90% of their initial volume within 1 month after the hepatectomy, whereas patients with injured livers regenerated gradually and regained approximately 80% of their preoperative value by 6 months after the hepatectomy.
CONCLUSIONS: We conclude that the measurement of functional hepatic volume using the GSA-LV is useful in fully evaluating hepatic function based on hepatocyte volume.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11232703     DOI: 10.1111/j.1572-0241.2001.03556.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  23 in total

Review 1.  Pharmaceutical strategies utilizing recombinant human serum albumin.

Authors:  Victor Tuan Giam Chuang; Ulrich Kragh-Hansen; Masaki Otagiri
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

2.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

3.  Relationship between CT volumetry and functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: a preliminary study.

Authors:  Atsushi Nanashima; Hiroyuki Yamaguchi; Shinichi Shibasaki; Shigeyuki Morino; Noboru Ide; Hiroaki Takeshita; Takashi Tsuji; Terumitsu Sawai; Tohru Nakagoe; Takeshi Nagayasu; Youji Ogawa
Journal:  Dig Dis Sci       Date:  2006-07       Impact factor: 3.199

4.  Liver regeneration in donors evaluated by Tc-99m-GSA scintigraphy after living donor liver transplantation.

Authors:  Masaki Kaibori; Sang Kil Ha-Kawa; Yoichiro Uchida; Morihiko Ishizaki; Takamichi Saito; Kosuke Matsui; Junko Hirohara; Koichi Tanaka; Yasuo Kamiyama
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

Review 5.  Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation.

Authors:  D Gomez; S Homer-Vanniasinkam; A M Graham; K R Prasad
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

6.  Hepatic resection is justified for elderly patients with hepatocellular carcinoma.

Authors:  Kazuhiro Kondo; Kazuo Chijiiwa; Mayumi Funagayama; Masahiro Kai; Kazuhiro Otani; Jiro Ohuchida
Journal:  World J Surg       Date:  2008-10       Impact factor: 3.352

7.  Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial.

Authors:  Toru Beppu; Hidetoshi Nitta; Hiromitsu Hayashi; Katsunori Imai; Hirohisa Okabe; Shigeki Nakagawa; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Morikatsu Yoshida; Yasuyuki Yamashita; Hideo Baba
Journal:  J Gastroenterol       Date:  2015-04-08       Impact factor: 7.527

Review 8.  Liver bioengineering: current status and future perspectives.

Authors:  Christopher Booth; Tom Soker; Pedro Baptista; Christina L Ross; Shay Soker; Umar Farooq; Robert J Stratta; Giuseppe Orlando
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

9.  Evaluation of liver functional reserve by combining D-sorbitol clearance rate and CT measured liver volume.

Authors:  Yi-Ming Li; Fan Lv; Xin Xu; Hong Ji; Wen-Tao Gao; Tuan-Jie Lei; Gui-Bing Ren; Zhi-Lan Bai; Qiang Li
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

10.  Surgical strategy for hepatocellular carcinoma patients with portal vein tumor thrombus based on prognostic factors.

Authors:  Kazuhiro Kondo; Kazuo Chijiiwa; Masahiro Kai; Kazuhiro Otani; Koki Nagaike; Jiro Ohuchida; Masahide Hiyoshi; Motoaki Nagano
Journal:  J Gastrointest Surg       Date:  2009-03-19       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.